OHSU Knight Cancer Institute Research Groups:OCI Cancer Journal Club: Difference between revisions

From OpenWetWare
Jump to navigationJump to search
No edit summary
(209 intermediate revisions by 11 users not shown)
Line 3: Line 3:
==Objectives of the OHSU Cancer Biology Journal Club==
==Objectives of the OHSU Cancer Biology Journal Club==


Cross-departmental workshop composed of students, postdocs, and faculty with shared interest in basic principles and emerging discoveries in Cancer Biology. The goals of the meetings and this wiki:
Cross-departmental journal club composed of students, postdocs, fellows and clinical and basic science faculty with shared interest in basic principles,  emerging discoveries, and new therapeutic approaches in Cancer Biology. The goals of the meetings are to:
* Establish a challenging and interactive cross-departmental focus group that will advance understanding of our individual projects and encourage collaborations.
* Critically evaluate new cutting edge literature on mechanisms underlying the development and maintenance of cancer to inform the development of new therapeutics. Papers should be paradigm shifting and set a backdrop for discussion into therapeutics facilitated by the clinical attendees.
*Provide students and postdocs with training and interactions with faculty interested in Cancer Biology and emerging therapeutics
*Provide students, postdocs and fellows with training and interactions with faculty interested in Cancer Biology and emerging therapeutics


==OCI CJC Activities==
==KCI CJC Information==
Want to join us? All are invited!
Want to join us? All are invited!
:To get on the listserve:  
*To get on the listserve:  
:Email: majordomoATohsu.edu  (must be sent as a plain text email)
:go to the following web site:
:subject: subscribe oncobio
:http://mailman.ohsu.edu/cgi-bin/mailman/listinfo/oncobio
:text box: subscribe oncobio
:follow instructions for subscribing
 
*To send out your paper
:Send an e-mail to 'oncobioATohsu.edu' with your paper attached
*When and where we meet
*When and where we meet
:MacHall 2136
:MacHall 2136
:Thursdays noon-1 PM
:Tuesdays noon-1 PM
:Lunch provided by OCI
:Lunch provided by KCI
*Organizer contact information: searsrATohsu.edu, lopezcATohsu.edu
*Organizer contact information:  
*
: Mushui Dai-daim@ohsu.edu
*
: David Qian-qianzh@ohsu.edu
: Charlie Lopez- lopezc@ohsu.edu


==Member Labs and Affiliations==
==Member Labs and Affiliations==
Line 49: Line 51:


|--
|--
|9/30/2010
|09/27/2016
|Rosie Sears
|
|Organization
|Organization
|
|
|--
|--
|10/7/2010
|10/4/2016
|Amy Farrell
|Kevin Watanabe-Smith
|Ubiquitylation of the amino terminus of Myc by SCF<sup>β-TrCp</sup> antagonizes SCF<sup>Fbw7</sup>-mediated turnover
|
|
|--
|10/11/2016
|Timothy Carey
|
|
|--
|10/18/2016
|Xiao-Xin Sun
|
|
|
|--
|--
|10/14/2010
|10/25/2016
|David Qian
|Lilli Klug
|Signaling Kinase AMPK Activates
|
Stress-Promoted Transcription via
|
Histone H2B Phosphorylation
|--  
|11/1/2016
|Marilynn Chow
|
|
|
|--
|--
|10/21/2010
|11/8/2016
|Anupriya Agarwal
|Sherif Abdelhamed
| Clinical efficacy of a RAF inhibitor needs broad target blockade in BRAF-mutant melanoma.
|
|
|--
|11/15/2016
|Chelsea Jenkins
|
|  
|  
|--
|--
|10/28/2010
|11/22/2016
|Deanne Tibbitts
|Ben Doron
| Effective targeting of quiescent chronic myelogenous leukemia stem cells by histone deacetylase inhibitors in combination with imatinib mesylate
|
|
|--
|11/4/2010
|Mushui Dai
|An ARF-Independent c-MYC-Activated Tumor Suppression Pathway Mediated by Ribosomal Protein-Mdm2 Interaction
|
|
|--
|--
|11/11/2010
|11/29/2016
|Katy Van Hook
|David Edwards
|Bacteri-Induced Gap Junctions in Tumors Favor Antigen Cross-Presentation and Antitumor Immunity
|
|
|
|--
|--
|11/18/2010
|12/06/2016
|Aaron Wortham
|Cymon Kersch
|Cytohesins Are Cytoplasmic ErbB Receptor Activators
|
|
|
|--
|--
|11/25/2010
|12/13/2016
|xxxxxxxxxx
|NO JC
|THANKSGIVING, NO JOURNAL CLUB
|
|xxxxxxxxxx
|
|--
|--
|12/2/2010
|12/20/2016
|Xiaoli Zhang
|NO JC
|A Stapled p53 Helix overcomes HDMX-mediated suppression of p53
|
|
|
|--
|--
|12/9/2010
|12/27/2016
|CANCELLED
|NO JC
|
|
|
|
|--
|--
|12/16/2010
|1/3/2017
|Beibei Dong
|Marilynn Chow
|Copper Transporter and Cisplatin
|
|
|
|--
|--
|1/6/2011
|1/10/2017
|Alain Silk
|Ben Doron
|Effective Suppression of Vascular Network Formation by Combination of Antibodies Blocking VEGFR Ligand Binding and Receptor Dimerization
|
|
|
|--
|--
|1/13/2011
|1/17/2017
|Xiao-Xin Sun
|Canceled
|Osteoclast differentiation factor RANKL controls development of progestin-driven mammary cancer; ( Schramek D et al,  Nature. 2010 Nov 4;468(7320):98-102)
|
|
|
|--
|--
|1/20/2011
|1/24/2017
|Eric Stoffregen
|Xiaoming Ouyang
|Epigenetic Antagonism between Polycomb and SWI/SNF Complexes during Oncohenic Transformation
|
|
|
|--
|--
|1/27/2011
|1/31/2017
|Mahnaz Janghorban
|Yingxiao Chen
|B55β-associated PP2A complex controls PDK1-directed myc signaling and modulates rapamycin sensitivity in colorectal cancer
|
|
|
|--
|--
|2/3/2011
|2/07/2017
|Katannya Kapeli
|Kevin Watanabe-Smith
|The miR-17-92 MicroRNA Cluster Regulates Multiple Components of the TGF-b Pathway in Neuroblastoma
|
|
|
|--
|--
|2/10/2011
|2/14/2017
|Jared Fischer
|Krishna Chauhan
|Intestinal crypt homeostasis results from neutral competition between symmetrically dividing Lgr5 stem cells
|
|[http://www.sciencedirect.com/science?_ob=ArticleURL&_udi=B6WSN-514HKDK-K&_user=1072900&_coverDate=10%2F01%2F2010&_rdoc=1&_fmt=high&_orig=search&_origin=search&_sort=d&_docanchor=&view=c&_acct=C000048262&_version=1&_urlVersion=0&_userid=1072900&md5=af1b7898b94d963f443267b44480597f&searchtype=a]
|
|--
|--
|2/17/2011
|2/21/2017
|Jason Link
|NO JC
|Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
|
|
|
|--
|--
|2/24/2011
|2/28/2017
|Rosie Sears
|Tyler Risom
|The blind spot of p53 <br> Stage-specific sensitivity to p53 restoration during lung cancer progression <br> Selective activation of p53-mediated tumour suppression in high-grade tumours
|
|
|
|--
|--
|3/3/2011
|3/07/2017
|Amy Skinner
|Lilli Klug
|Bone Marrow-Derived Myofibroblasts Contribute to the Mesenchymal Stem Cell Niche and Promote Tumor Growth
|
|
|
|--
|--
|3/10/2011
|3/14/2017
|Tiffany DeVine
|Xiaoming Ouyang
|Activation of mTORC2 by Association with the Ribosome
|
|
|
|--
|--
|3/17/2011
|3/21/2017
|Aaron Jacobs
|Canceled, spring break
|Identification of Aneuploidy-Selective Antiproliferation Compounds
|
|
|
|--
|--
|3/31/2011
|3/28/2017
|Harini Sampath
|David Edwards
|Dietary and genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression
|
|
|
|--
|--
|4/7/2011
|4/4/2017
|Yun Xin Lim
|Cymon Kersch
|Sensitivity to Atitubulin Chemotherapeutics is Regulated by MC:1 and FBW7
|
|
|
|--
|--
|4/14/2011
|4/11/2017
|Gregory Gores, M.D.
|Chelsea Jenkins
Division of Gastroenterology and Hepatology Mayo Clinic, Rochester, MN
|
|TRAIL triggers the lysosomal pathway of apoptosis
|
|Vollum M1441
|--
|--
|4/21/2011
|4/18/2017
|Liangqi Xie
|
|Rapid Scalable RNA1 in Mice
|
|
|
|--
|--
|4/28/2011
|4/25/2017
|Kinrin Yamanaka
|
|DNA damage-mediated induction of chemoresistant niche
|
|
|
|--
|--
|5/5/2011
|5/2/2017
|Kishore Challagundla
|Canceled---research week
|LIN-28 co-transcriptionally binds primary let-7 to regulate miRNA maturation in Caenorhabditis elegans
|
|
|--
|--
|5/12/2011
|5/9/2017
|Ben Doron
|
|
|*****STUDENT RESEARCH FORUM*****
|
|
|--
|--
|5/19/2011
|5/16/2017
|Jeff Wu
|
|Brusatol enhances the efficacy of chemotherapy by inhibiting the Nrf2-mediated defense mechanism
|
|
|
|--
|--
|5/26/2011
|5/23/2017
|Vince Bicocca
|
|AKT Inhibition Relieves Feedback Suppression of Receptor Tyrosine Kinase Expression and Activity
|
|
|
|--
|--
|6/2/2010
|5/30/2017
|Xiangshu Xiao
|Tyler Risom
|Mechanistic Rationale for Inhibition of Poly(ADP-Ribose) Polymerase in ETS Gene Fusion-Positive Prostate Cancer
|
|
|
|--
|--
|6/9/2011
|6/06/2016
|Arun Krishnamoorthy
|
|Combating trastuzumab resistance by targeting SRC, a common node downstream of multiple resistance pathways
|
|
|}
|}
</div>
</div>

Revision as of 10:16, 20 February 2017

Equipped with his five senses, man explores the universe around him and calls the adventure Science. ~Edwin Powell Hubble, The Nature of Science, 1954

Home        Faculty        Graduate Program        Postdocs        OHSU Knight Core Facilities       



Programs     Res Group Meetings        Cancer Journal Club        Cell/CANB 616        Gen. Inst/R3 Club     CANB 610    


Objectives of the OHSU Cancer Biology Journal Club

Cross-departmental journal club composed of students, postdocs, fellows and clinical and basic science faculty with shared interest in basic principles, emerging discoveries, and new therapeutic approaches in Cancer Biology. The goals of the meetings are to:

  • Critically evaluate new cutting edge literature on mechanisms underlying the development and maintenance of cancer to inform the development of new therapeutics. Papers should be paradigm shifting and set a backdrop for discussion into therapeutics facilitated by the clinical attendees.
  • Provide students, postdocs and fellows with training and interactions with faculty interested in Cancer Biology and emerging therapeutics

KCI CJC Information

Want to join us? All are invited!

  • To get on the listserve:
go to the following web site:
http://mailman.ohsu.edu/cgi-bin/mailman/listinfo/oncobio
follow instructions for subscribing
  • To send out your paper
Send an e-mail to 'oncobioATohsu.edu' with your paper attached
  • When and where we meet
MacHall 2136
Tuesdays noon-1 PM
Lunch provided by KCI
  • Organizer contact information:
Mushui Dai-daim@ohsu.edu
David Qian-qianzh@ohsu.edu
Charlie Lopez- lopezc@ohsu.edu

Member Labs and Affiliations

Lopez Lab Hem Onc

Sears Lab

Hoatlin Lab

Thayer Lab

Wong Lab

Lloyd Lab CROET

McCullough Lab CROET

Schedule

  • Scheduling In Progress
Date Presenters Topic Links & Comments
09/27/2016 Organization
10/4/2016 Kevin Watanabe-Smith
10/11/2016 Timothy Carey
10/18/2016 Xiao-Xin Sun
10/25/2016 Lilli Klug
11/1/2016 Marilynn Chow
11/8/2016 Sherif Abdelhamed
11/15/2016 Chelsea Jenkins
11/22/2016 Ben Doron
11/29/2016 David Edwards
12/06/2016 Cymon Kersch
12/13/2016 NO JC
12/20/2016 NO JC
12/27/2016 NO JC
1/3/2017 Marilynn Chow
1/10/2017 Ben Doron
1/17/2017 Canceled
1/24/2017 Xiaoming Ouyang
1/31/2017 Yingxiao Chen
2/07/2017 Kevin Watanabe-Smith
2/14/2017 Krishna Chauhan
2/21/2017 NO JC
2/28/2017 Tyler Risom
3/07/2017 Lilli Klug
3/14/2017 Xiaoming Ouyang
3/21/2017 Canceled, spring break
3/28/2017 David Edwards
4/4/2017 Cymon Kersch
4/11/2017 Chelsea Jenkins
4/18/2017
4/25/2017
5/2/2017 Canceled---research week
5/9/2017 Ben Doron
5/16/2017
5/23/2017
5/30/2017 Tyler Risom
6/06/2016
Retrieved from "https://openwetware.org/mediawiki/index.php?title=OHSU_Knight_Cancer_Institute_Research_Groups:OCI_Cancer_Journal_Club&oldid=975565"